Literature DB >> 18684930

Leukocyte extravasation: an immunoregulatory role for alpha-L-fucosidase?

Simi Ali1, Yvonne Jenkins, Maureen Kirkley, Athanasios Dagkalis, Ayyakkannu Manivannan, Isabel Joan Crane, John A Kirby.   

Abstract

Fucosylated oligosaccharides and glycoconjugates have been implicated in several biological events, including the cell-cell adhesion processes that mediate inflammation. Alpha-L-fucosidase (ALF) is an exoglycosidase that is involved in the hydrolytic degradation of alpha-L-fucose from glycoconjugates. In this study, we investigated the potential role of ALF in regulation of leukocyte migration. Measurement of transendothelial migration in response to CCL5 demonstrated that pretreatment of monocytic cells with ALF reduced migration (p = 0.0004) to a greater extent than treatment of the endothelial monolayer (p = 0.0374). Treatment with ALF significantly reduced the adhesion of monocytic cells to immobilized P-selectin.Fc. A murine model of experimental autoimmune uveitis was then used to show that treatment of splenic cells with ALF produced an 8.6-fold decrease in rolling and a 3.2-fold decrease in cell migration across the retinal vasculature. Further in vitro studies demonstrated that treatment of monocytes with the chemokines CCL3 or CCL5 increased the level of mRNA encoding ALF; this was accompanied by the detection of significant increases in both the 51- and 56-kDa components of ALF by Western blotting. Treatment of monocytic cells with ALF for 2 h significantly reduced the cell surface expression of CD31, with a further decrease in expression observed after 5 h (p = 0.002). Thus, CD31 and fucosylated ligands of P-selectin seem to be the candidates through which ALF mediates its effect in vitro. These data identify a previously unrecognized immunoregulatory role for ALF in late stages of inflammation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18684930      PMCID: PMC2665703          DOI: 10.4049/jimmunol.181.4.2407

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  32 in total

1.  Value of the serum alpha-L-fucosidase activity in the diagnosis of colorectal cancer.

Authors:  D Ayude; J Fernández-Rodríguez; F J Rodríguez-Berrocal; V S Martínez-Zorzano; A de Carlos; E Gil; M Páez de La Cadena
Journal:  Oncology       Date:  2000-11       Impact factor: 2.935

Review 2.  Golgi nucleotide sugar transport and leukocyte adhesion deficiency II.

Authors:  C B Hirschberg
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

3.  Cell surface human alpha-L-fucosidase.

Authors:  O J Cordero; A Merino; M Páez de la Cadena; B Bugía; M Nogueira; J E Viñuela; V S Martínez-Zorzano; A de Carlos; F J Rodríguez-Berrocal
Journal:  Eur J Biochem       Date:  2001-06

4.  Analysis of purified human liver alpha-L-fucosidase by western-blotting with lectins and polyclonal and monoclonal antibodies.

Authors:  S W Johnson; S Piesecki; R F Wang; I Damjanov; J A Alhadeff
Journal:  Biochem J       Date:  1992-03-15       Impact factor: 3.857

5.  Serum alpha L-fucosidase enzyme activity in ovarian and other female genital tract tumors.

Authors:  H Abdel-Aleem; A Ahmed; A M Sabra; M Zakhari; M Soliman; H Hamed
Journal:  Int J Gynaecol Obstet       Date:  1996-12       Impact factor: 3.561

6.  The effects of inhibiting leukocyte migration with fucoidin in a rat peritonitis model.

Authors:  G Linnemann; K Reinhart; U Parade; A Philipp; W Pfister; E Straube; W Karzai
Journal:  Intensive Care Med       Date:  2000-10       Impact factor: 17.440

7.  Immunocytochemical localization and biochemical characterization of a novel plasma membrane-associated, neutral pH optimum alpha-L-fucosidase from rat testis and epididymal spermatozoa.

Authors:  M Avilés; I Abascal; J A Martínez-Menárguez; M T Castells; S R Skalaban; J Ballesta; J A Alhadeff
Journal:  Biochem J       Date:  1996-09-15       Impact factor: 3.857

8.  Inhibition of leukocyte rolling with polysaccharide fucoidin prevents pleocytosis in experimental meningitis in the rabbit.

Authors:  C Granert; J Raud; X Xie; L Lindquist; L Lindbom
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

9.  Migration of monocytes across endothelium and passage through extracellular matrix involve separate molecular domains of PECAM-1.

Authors:  F Liao; H K Huynh; A Eiroa; T Greene; E Polizzi; W A Muller
Journal:  J Exp Med       Date:  1995-11-01       Impact factor: 14.307

10.  PECAM-1 is required for transendothelial migration of leukocytes.

Authors:  W A Muller; S A Weigl; X Deng; D M Phillips
Journal:  J Exp Med       Date:  1993-08-01       Impact factor: 14.307

View more
  14 in total

1.  Plasma alpha-L-fucosidase activity in chronic inflammation and autoimmune disorders in a pediatric cohort of hospitalized patients.

Authors:  Ildikó Endreffy; Geir Bjørklund; László Szerafin; Salvatore Chirumbolo; Mauricio A Urbina; Emőke Endreffy
Journal:  Immunol Res       Date:  2017-10       Impact factor: 2.829

2.  Modulating Cell-Surface Receptor Signaling and Ion Channel Functions by In Situ Glycan Editing.

Authors:  Hao Jiang; Aimé López-Aguilar; Lu Meng; Zhongwei Gao; Yani Liu; Xiao Tian; Guangli Yu; Ben Ovryn; Kelley W Moremen; Peng Wu
Journal:  Angew Chem Int Ed Engl       Date:  2018-01-02       Impact factor: 15.336

3.  Association between serum α-L-fucosidase and non-alcoholic fatty liver disease: Cross-sectional study.

Authors:  Zhen-Ya Lu; Chao Cen; Zhou Shao; Xin-Hua Chen; Cheng-Fu Xu; You-Ming Li
Journal:  World J Gastroenterol       Date:  2016-02-07       Impact factor: 5.742

4.  The emerging importance of α-L-fucose in human breast cancer: a review.

Authors:  Jay J Listinsky; Gene P Siegal; Catherine M Listinsky
Journal:  Am J Transl Res       Date:  2011-07-20       Impact factor: 4.060

Review 5.  Regulation of intracellular signaling by extracellular glycan remodeling.

Authors:  Randy B Parker; Jennifer J Kohler
Journal:  ACS Chem Biol       Date:  2010-01-15       Impact factor: 5.100

6.  Modulation of expression in BEAS-2B airway epithelial cells of α-L-fucosidase A1 and A2 by Th1 and Th2 cytokines, and overexpression of α-L-fucosidase 2.

Authors:  Anna D Sobkowicz; Mary E Gallagher; Colm J Reid; Daniel Crean; Stephen D Carrington; Jane A Irwin
Journal:  Mol Cell Biochem       Date:  2014-01-28       Impact factor: 3.396

7.  Receptor recognition by meningococcal type IV pili relies on a specific complex N-glycan.

Authors:  Loic Le Guennec; Zoé Virion; Haniaa Bouzinba-Ségard; Catherine Robbe-Masselot; Renaud Léonard; Xavier Nassif; Sandrine Bourdoulous; Mathieu Coureuil
Journal:  Proc Natl Acad Sci U S A       Date:  2020-01-21       Impact factor: 11.205

8.  Functional exploration of the GH29 fucosidase family.

Authors:  Hendrik Grootaert; Linde Van Landuyt; Paco Hulpiau; Nico Callewaert
Journal:  Glycobiology       Date:  2020-08-20       Impact factor: 4.313

9.  Alpha-1-fucosidase as a prognostic indicator for hepatocellular carcinoma following hepatectomy: a large-scale, long-term study.

Authors:  K Wang; W Guo; N Li; J Shi; C Zhang; W Y Lau; M Wu; S Cheng
Journal:  Br J Cancer       Date:  2014-02-25       Impact factor: 7.640

10.  Human a-L-fucosidase-1 attenuates the invasive properties of thyroid cancer.

Authors:  Giancarlo Vecchio; Alessia Parascandolo; Chiara Allocca; Clara Ugolini; Fulvio Basolo; Marco Moracci; Andrea Strazzulli; Beatrice Cobucci-Ponzano; Mikko O Laukkanen; Maria Domenica Castellone; Nobuo Tsuchida
Journal:  Oncotarget       Date:  2017-04-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.